Why the study?
The field of proteomics has matured rapidly over 20 years, yet challenges remain before proteomic technologies can be readily translated from scientific discoveries into meaningful advances in cardiovascular care. Guidance is needed on evaluating the current status of the field and using next-generation proteomics in basic research and clinical settings.
This scientific statement summarizes 20 years of advances in cardiovascular proteomics and provides guidance on integrating next-generation proteomic technologies into basic research and clinical care.
Answers are grounded in this paper and cite their sources.
Supports proteomic integration into CV diagnostics now; extends 20-year mass spectrometry maturation toward clinical algorithms.
The year 2014 marked the 20th anniversary of the coining of the term proteomics. The purpose of this scientific statement is to summarize advances over this period that have catalyzed our capacity to address the experimental, translational, and clinical implications of proteomics as applied to cardiovascular health and disease and to evaluate the current status of the field. Key successes that have energized the field are delineated; opportunities for proteomics to drive basic science research, facilitate clinical translation, and establish diagnostic and therapeutic healthcare algorithms are discussed; and challenges that remain to be solved before proteomic technologies can be readily translated from scientific discoveries to meaningful advances in cardiovascular care are addressed. Proteomics is the result of disruptive technologies, namely, mass spectrometry and database searching, which drove protein analysis from 1 protein at a time to protein mixture analyses that enable large-scale analysis of proteins and facilitate paradigm shifts in biological concepts that address important clinical questions. Over the past 20 years, the field of proteomics has matured, yet it is still developing rapidly. The scope of this statement will extend beyond the reaches of a typical review article and offer guidance on the use of next-generation proteomics for future scientific discovery in the basic research laboratory and clinical settings.
No takes yet. Share an insight, caveat, or question.
Lindsey et al. (2015) conducted a review in Cardiovascular health and disease. Proteomics was evaluated. Proteomics technologies, such as mass spectrometry and database searching, have matured over 20 years to drive basic research and clinical translation in cardiovascular care.
Synapse has enriched 10 related papers. Consider them for comparative context: